(NYSE: SCL) Stepan Co's forecast annual revenue growth rate of 7.25% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.89%.
Stepan Co's revenue in 2026 is $2,332,114,000.On average, 3 Wall Street analysts forecast SCL's revenue for 2026 to be $56,271,298,622, with the lowest SCL revenue forecast at $53,668,241,767, and the highest SCL revenue forecast at $59,508,143,233. On average, 3 Wall Street analysts forecast SCL's revenue for 2027 to be $59,236,519,909, with the lowest SCL revenue forecast at $56,384,475,007, and the highest SCL revenue forecast at $62,744,987,844.
In 2028, SCL is forecast to generate $66,004,467,732 in revenue, with the lowest revenue forecast at $64,057,833,910 and the highest revenue forecast at $68,630,159,864.